Charles River Laboratories and Insightec collaborate for 5 years to enhance neuroscience drug discovery with focused ultrasound technology.

Charles River Laboratories and Insightec have teamed up for a five-year collaboration to enhance drug discovery and development in neuroscience using focused ultrasound technology. Insightec's method non-invasively alters the blood-brain barrier, allowing for targeted drug delivery to deep brain regions. This partnership aims to improve therapies for challenging CNS conditions, including neurodegenerative diseases and cancers, ultimately benefiting patient outcomes.

September 04, 2024
5 Articles